🔔 Get instant alerts when GLAXO files quarterly results on BSE Start free trial →

GlaxoSmithKline Pharmaceuticals Limited — Financials & Forensics

Sector: Healthcare · NSE: GLAXO · BSE: 500660 · ISIN: INE159A01016

₹2,883.20
Closing price
18 Aug 2026
+3.2%
1-year price change
₹48,844 Cr
Market cap
47.1×
P/E ratio (trailing)
51.0%
Return on Equity (FY)
1.46%
Dividend yield
⚡ What you get within minutes of every filing
ISA
Indian Stock Alerts BOT
🚨 GLAXO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add GLAXO to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime
GLAXO price
→
Loading…
Compare with:
Loading chart…

Annual P&L snapshot

Line item FY21FY22FY23FY24FY26
Revenue from operations ₹3,199 Cr ₹3,278 Cr ₹3,252 Cr ₹3,454 Cr ₹3,822 Cr
EBITDA ₹695 Cr ₹762 Cr ₹804 Cr ₹909 Cr ₹1,309 Cr
EBITDA margin 21.7% 23.2% 24.7% 26.3% 34.3%
Profit after tax ₹358 Cr ₹381 Cr ₹608 Cr ₹590 Cr ₹1,036 Cr

Source: GlaxoSmithKline Pharmaceuticals Limited's regulatory filings under SEBI LODR Regulation 33. View full financials →

Deeper analysis

🔍 Forensic red-flag screen
Automated screen across audit / governance / accruals / RPT / pledge dimensions. Score, verdict and top flagged items.
🤝 Related-party transactions
RPT volume, transaction count, materiality flag from the latest SEBI integrated filing under Regulation 23(9).

Recent filings by GlaxoSmithKline Pharmaceuticals Limited

Never miss a filing again

1
Sign in with Google
2
Add stocks to watchlist
3
Get instant Telegram alerts
Get started — it's free →
14-day Pro trial included · No credit card required

About GlaxoSmithKline Pharmaceuticals Limited on Indian Stock Alerts

Indian Stock Alerts tracks GlaxoSmithKline Pharmaceuticals Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.

Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.

Important. All data on this page is sourced from GlaxoSmithKline Pharmaceuticals Limited's own public regulatory filings under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Investors should consult registered advisers before making investment decisions.
Notice a data issue? Filings are extracted automatically and may occasionally contain parse errors. Email support@indianstockalerts.com with the URL and we'll correct within 24 hours.